已收录 268920 条政策
 政策提纲
  • 暂无提纲
Inactivating BTK mutations in large B-cell lymphoma in a real-world cohort: Strong correlation with BCL2 translocation
[摘要] Inactivating mutations in Bruton's tyrosine kinase ( BTK ) in patients with follicular lymphoma (FL) have recently been reported. These mutations were found in BTK inhibitor-treatment naïve patients. Here, we report the BTK mutation status in a real-world cohort of patients with non-Hodgkin lymphoma. We found primary BTK mutations in 7.7% of patients with large B-cell lymphoma (LBCL) and in 14.1% of patients with FL. All patients with BTK -mutated LBCL were BCL2 translocation positive, and the correlation between BCL2 translocation and BTK mutation persisted even when patients with known transformation from FL were excluded.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 
[关键词] BTK;molecular pathology;non-Hodgkin lymphoma [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文